Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 04/30/14
Due: 04/30/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) | NCT01464905 | Nuron Biotech Inc. | user2@example.com | None | 2011-10-31 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |
| A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers | NCT01732198 | Nuron Biotech Inc. | user2@example.com | None | 2013-03-31 | 2014-04-30 | 2015-04-30 | - | - | 2025-07-14 |